Proposal for a program to enhance renal transplantation opportunity for highly sensitized patients

Purpose: The accumulation of highly sensitized patients (HSP) on renal transplant waiting lists is a universal problem and finding donors for them represents a major challenge for organ distribution organizations. The purpose of this report is to describe a possible Brazilian version of the Eurotransplant Acceptable Mismatch program and the results of a study performed to test its efficiency. Method: The acceptable mismatches were defined with the single antigen beads Luminex assay, each test being individually interpreted with aid of the HLAMatchmaker algorithm. Negative-crossmatch prediction was validated in 86 T cell crossmatches using complement dependent cytotoxicity with anti-human globulin. Results: The estimation of the chances of 40 HSP to find a donor through the program showed that about 70% of them would be offered an ABO compatible, zero HLA-DR mismatched, T and B cell crossmatch negative graft within a two-year period after joining the program. On the other hand, for about 30% of the patients, the chances to find a suitable donor would be minimal, even after three or five years. Conclusions: We estimated that around 70% of the HSP would clearly benefit from the algorithm proposed in this study. On the other hand, those patients for whom it would be highly improbable to find a compatible donor would be primary candidates for desensitization/antibody reduction protocols. Therefore, we concluded that the information regarding the transplantability of each HSP provided by the algorithm herein described is a powerful tool for a proper management of highly sensitized patients in regional, national and international organizations as to deceased donor kidneys distribution.

[1]  J. Bryant,et al.  72-P: Correlation of flow cytometric crossmatch and Luminex for the detection of HLA antibodies , 2009 .

[2]  J. Schmitz,et al.  56-P: Prediction of flow cytometry and AHG-CDC crossmatch results by multiplex bead array MFI , 2009 .

[3]  I. Doxiadis,et al.  Management of the highly sensitized patient. , 2009, Current opinion in immunology.

[4]  A. Rahmel,et al.  Enhanced kidney allocation to highly sensitized patients by the acceptable mismatch program. , 2009, Transplantation.

[5]  Jeffrey T. Sholander,et al.  Using real data for a virtual crossmatch. , 2009, Human immunology.

[6]  R. Duquesnoy,et al.  HLAMatchmaker-based definition of structural human leukocyte antigen epitopes detected by alloantibodies , 2009, Current opinion in organ transplantation.

[7]  V. D’Agati,et al.  Sensitivity, specificity and clinical relevance of different cross-matching assays in deceased-donor renal transplantation. , 2008, Transplant immunology.

[8]  P. Terasaki,et al.  “Natural” Human Leukocyte Antigen Antibodies Found in Nonalloimmunized Healthy Males , 2008, Transplantation.

[9]  S. Jordan,et al.  Rituximab and intravenous immune globulin for desensitization during renal transplantation. , 2008, The New England journal of medicine.

[10]  J. Bradley,et al.  Utility of HLAMatchmaker and Single-Antigen HLA-Antibody Detection Beads for Identification of Acceptable Mismatches in Highly Sensitized Patients Awaiting Kidney Transplantation , 2006, Transplantation.

[11]  S. Jordan,et al.  Intravenous Gammaglobulin (IVIG): A Novel Approach to Improve Transplant Rates and Outcomes in Highly HLA‐Sensitized Patients , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[12]  I. Doxiadis,et al.  The acceptable mismatch program as a fast tool for highly sensitized patients awaiting a cadaveric kidney transplantation: short waiting time and excellent graft outcome. , 2004, Transplantation.

[13]  I. Doxiadis,et al.  THE ACCEPTABLE MISMATCH PROGRAM AS A FAST TOOL TO TRANSPLANT HIGHLY SENSITISED PATIENTS AWAITING A CADAVER KIDNEY: SHORT WAITING TIME AND EXCELLENT GRAFT OUTCOME. , 2004 .

[14]  F. Ward,et al.  Regional organ procurement (ROP) trays in renal allograft distribution and outcome. , 1997, Clinical Transplantation.

[15]  C. Bryan,et al.  Sharing kidneys across donor‐service area boundaries with sensitized candidates can be influenced by HLA C , 2010, Clinical transplantation.

[16]  I. Doxiadis,et al.  HLAMatchmaker-based strategy to identify acceptable HLA class I mismatches for highly sensitized kidney transplant candidates , 2004, Transplant international : official journal of the European Society for Organ Transplantation.

[17]  R. McCalmon,et al.  SEOPF high-grade match algorithm: the effect of HLA matching with ROP trays in transplanting highly sensitized patients. Southern Organ Procurement Foundation. , 1996, Clinical Transplantation.

[18]  F. Claas,et al.  Transplantation of highly sensitized patients on the basis of acceptable HLA-A and B mismatches. , 1989, Clinical transplants.